Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Assessment of protection against malaria by sporozoite challenge of healthy adults vaccinated with AdCh63 ME-TRAP and MVA ME-TRAP
2007-004360-44Phase 2Terminated
- Sponsor
- University of Oxford
- Start
- Mar 2008
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of ChAd63 ME-TRAP and MVA ME-TRAP in malaria (3 arms), sponsored by University of Oxford. Primary endpoints: Protection against malaria infection, Time to parasitaemia and 1 more. Started Mar 2008; status: terminated.
02
Drugs
ChAd63 ME-TRAPMVA ME-TRAP
03
Conditions
malaria
Beyond the preview
Go deeper on 2007-004360-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004360-44.